Company / SG&A Expense
Equillium, Inc. SG&A Expense History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$11.9M
FY2025
5-year range
$11.4M / $17.2M
FY2022-FY2025
Trend
-12.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $17M to $12M over the past 2 years.
Based on SEC 10-K filings.
$12M in FY2025 with a 3-year CAGR of +1.5%.
Improved from $17M to $12M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +1.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +1.5%, indicating consistent growth.
- In FY2025, sg&a expense decreased 12.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.9M | -12.0% |
| FY2024 | $13.6M | -21.3% |
| FY2023 | $17.2M | +51.1% |
| FY2022 | $11.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026